Patel Kinnari's Form 4 filing
Rocket Pharmaceuticals, Inc. (RCKT) · filed May 22, 2025
- Accession no.
- 0001140361-25-020161
- Filed
- May 22, 2025
- Trade date
- May 20, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $4.95K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel KinnariCIK 0001725929 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Common Stock | SSaleDisposed | −767 | $6.45 | −$4,947.15 | 441,927 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.